- Home
- / Nanjing King-Friend Biochemical Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nanjing King-Friend Biochemical Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
¥14.4
2024-10-29
Market Capitalization
¥23.3 B
2024-10-29
Revenue
¥4 B
FY, 2025
CreditSafe Score
?
Score changed on Jul 22, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7B | 2.5B | 2.9B | 3.7B | 3.7B | 3.9B | 3.9B | 4.0B |
| Cost of goods sold | 859.2M | 1.2B | 1.2B | 1.6B | 1.8B | 2.0B | 2.2B | 2.4B |
| Gross profit | 837.1M | 1.3B | 1.7B | 2.1B | 1.9B | 1.8B | 1.7B | 1.5B |
| Gross profit margin, % | 51.2% | 59.0% | 56.5% | 52.0% | 47.8% | 43.0% | 39.0% | |
| Operating expense total | 346.7M | 541.0M | 657.4M | 738.3M | 760.9M | 787.8M | 632.9M | 748.7M |
| Depreciation and amortization | 40.5M | 47.6M | 82.6M | 92.6M | 142.1M | 151.0M | 199.9M | 253.3M |
| EBITDA | 491.1M | 723.2M | 1.1B | 1.3B | 1.2B | 1.1B | 1.0B | 798.5M |
| EBITDA margin, % | 29.4% | 36.4% | 36.5% | 31.9% | 27.4% | 26.8% | 20.2% | |
| EBIT | 458.5M | 685.8M | 962.0M | 1.3B | 1.0B | (280.2M) | 998.3M | 795.4M |
| EBIT margin, % | 27.8% | 33.1% | 34.5% | 28.0% | -7.2% | 25.6% | 20.1% | |
| Interest income | 6.5M | 3.4M | 1.5M | 12.0M | 33.4M | 28.0M | 19.2M | 18.6M |
| Interest expense | 9.0M | 22.1M | 57.6M | 92.2M | 57.8M | 81.0M | 75.7M | 55.3M |
| Pre tax profit | 467.7M | 680.4M | 914.6M | 1.2B | 1.2B | (294.8M) | 992.0M | 699.4M |
| Income tax expense | 43.2M | 74.1M | 118.0M | 139.8M | 98.9M | (105.3M) | 165.9M | 117.9M |
| Net Income | 424.5M | 606.2M | 796.7M | 1.1B | 1.1B | (189.4M) | 826.1M | 581.5M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |